FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070242543> ?p ?o ?g. }

• W2070242543 endingPage "257" @default.
• W2070242543 startingPage "250" @default.
• W2070242543 abstract "We investigated the efficacy of glimepiride, a third-generation sulfonylurea (SU), in Japanese type 2 diabetic patients in whom glycemic control had been inadequate with a conventional SU, gliclazide or glibenclamide. A total of 172 Japanese type 2 diabetic patients (HbA1C ≥ 7.0%), maintained on a conventional SU, were randomly assigned to the 3rd SU group (SU treatments switched to glimepiride) or the 2nd SU group (treatments not changed). The conventional SU was switched to the indicated doses of glimepiride (gliclazide 40 mg = glimepiride 1 mg, glibenclamide 2.5 mg = glimepiride 2 mg). After 6 months, glycemic control (HbA1C and fasting plasma glucose) had not changed significantly in either the 2nd or the 3rd SU group. The homeostasis assessment model of insulin resistance (HOMA-IR) in the 3rd SU group was decreased by more than 10% (p = 0.015), whereas no change was observed in the 2nd SU group. The triglyceride level was decreased by approximately 10% in the 3rd SU group, not a significant change (p = 0.080). Patients who had been treated with only SU, or treated with SU for a short time (less than 5 years), and who were also obese (BMI ≥ 25) or had a high HOMA-IR (HOMA-IR ≥ 3), showed significantly reduced insulin resistance. According to logistic regression analysis, high BMI (≥25) was the only variable predicting that glimepiride would more effectively improve HbA1C than conventional SU treatment. In conclusion, switching conventional SUs to glimepiride reduced insulin resistance without improving glycemic control. A notable finding of this study is that glimepiride was more beneficial in obese than in non-obese Japanese type 2 diabetic patients." @default.
• W2070242543 created "2016-06-24" @default.
• W2070242543 creator A5005160088 @default.
• W2070242543 creator A5006861620 @default.
• W2070242543 creator A5010379630 @default.
• W2070242543 creator A5012039871 @default.
• W2070242543 creator A5014137022 @default.
• W2070242543 creator A5018199873 @default.
• W2070242543 creator A5024966104 @default.
• W2070242543 creator A5028520101 @default.
• W2070242543 creator A5043984865 @default.
• W2070242543 creator A5056825979 @default.
• W2070242543 creator A5058636714 @default.
• W2070242543 creator A5076592058 @default.
• W2070242543 date "2005-06-01" @default.
• W2070242543 modified "2023-09-26" @default.
• W2070242543 title "Efficacy of glimepiride in Japanese type 2 diabetic subjects" @default.
• W2070242543 cites W1981261500 @default.
• W2070242543 cites W1994860175 @default.
• W2070242543 cites W2023893435 @default.
• W2070242543 cites W2042706232 @default.
• W2070242543 cites W2042771878 @default.
• W2070242543 cites W2043744013 @default.
• W2070242543 cites W2049965571 @default.
• W2070242543 cites W2059185496 @default.
• W2070242543 cites W2065569245 @default.
• W2070242543 cites W2077230920 @default.
• W2070242543 cites W2083244363 @default.
• W2070242543 cites W2089768547 @default.
• W2070242543 cites W2116836307 @default.
• W2070242543 cites W2118723490 @default.
• W2070242543 cites W2142470321 @default.
• W2070242543 cites W2158049984 @default.
• W2070242543 cites W2159693162 @default.
• W2070242543 cites W2171242446 @default.
• W2070242543 cites W4233851524 @default.
• W2070242543 cites W4236896122 @default.
• W2070242543 cites W4237617875 @default.
• W2070242543 cites W4242585065 @default.
• W2070242543 cites W4247735996 @default.
• W2070242543 cites W4256717600 @default.
• W2070242543 cites W92458862 @default.
• W2070242543 doi "https://doi.org/10.1016/j.diabres.2004.10.002" @default.
• W2070242543 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15936468" @default.
• W2070242543 hasPublicationYear "2005" @default.
• W2070242543 type Work @default.
• W2070242543 sameAs 2070242543 @default.
• W2070242543 citedByCount "32" @default.
• W2070242543 countsByYear W20702425432012 @default.
• W2070242543 countsByYear W20702425432013 @default.
• W2070242543 countsByYear W20702425432014 @default.
• W2070242543 countsByYear W20702425432015 @default.
• W2070242543 countsByYear W20702425432016 @default.
• W2070242543 countsByYear W20702425432019 @default.
• W2070242543 crossrefType "journal-article" @default.
• W2070242543 hasAuthorship W2070242543A5005160088 @default.
• W2070242543 hasAuthorship W2070242543A5006861620 @default.
• W2070242543 hasAuthorship W2070242543A5010379630 @default.
• W2070242543 hasAuthorship W2070242543A5012039871 @default.
• W2070242543 hasAuthorship W2070242543A5014137022 @default.
• W2070242543 hasAuthorship W2070242543A5018199873 @default.
• W2070242543 hasAuthorship W2070242543A5024966104 @default.
• W2070242543 hasAuthorship W2070242543A5028520101 @default.
• W2070242543 hasAuthorship W2070242543A5043984865 @default.
• W2070242543 hasAuthorship W2070242543A5056825979 @default.
• W2070242543 hasAuthorship W2070242543A5058636714 @default.
• W2070242543 hasAuthorship W2070242543A5076592058 @default.
• W2070242543 hasConcept C126322002 @default.
• W2070242543 hasConcept C134018914 @default.
• W2070242543 hasConcept C2776307423 @default.
• W2070242543 hasConcept C2777180221 @default.
• W2070242543 hasConcept C2777391703 @default.
• W2070242543 hasConcept C2777448766 @default.
• W2070242543 hasConcept C2778163477 @default.
• W2070242543 hasConcept C2778854520 @default.
• W2070242543 hasConcept C2778913445 @default.
• W2070242543 hasConcept C2779306644 @default.
• W2070242543 hasConcept C2779768347 @default.
• W2070242543 hasConcept C2780473172 @default.
• W2070242543 hasConcept C555293320 @default.
• W2070242543 hasConcept C71924100 @default.
• W2070242543 hasConcept C90924648 @default.
• W2070242543 hasConceptScore W2070242543C126322002 @default.
• W2070242543 hasConceptScore W2070242543C134018914 @default.
• W2070242543 hasConceptScore W2070242543C2776307423 @default.
• W2070242543 hasConceptScore W2070242543C2777180221 @default.
• W2070242543 hasConceptScore W2070242543C2777391703 @default.
• W2070242543 hasConceptScore W2070242543C2777448766 @default.
• W2070242543 hasConceptScore W2070242543C2778163477 @default.
• W2070242543 hasConceptScore W2070242543C2778854520 @default.
• W2070242543 hasConceptScore W2070242543C2778913445 @default.
• W2070242543 hasConceptScore W2070242543C2779306644 @default.
• W2070242543 hasConceptScore W2070242543C2779768347 @default.
• W2070242543 hasConceptScore W2070242543C2780473172 @default.
• W2070242543 hasConceptScore W2070242543C555293320 @default.
• W2070242543 hasConceptScore W2070242543C71924100 @default.
• W2070242543 hasConceptScore W2070242543C90924648 @default.
• W2070242543 hasIssue "3" @default.

• next